Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 69 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

Gemcitabine 302 Fluorouracil 296 Oxaliplatin 269 Bevacizumab 268 Capecitabine 233 Leucovorin 228 pembrolizumab 215 Irinotecan 185 Cisplatin 142 Cetuximab 142 Nivolumab 131 Paclitaxel 117 130-nm albumin-bound paclitaxel 117 Sorafenib 86 Albumin-Bound Paclitaxel 75 Docetaxel 65 regorafenib 64 atezolizumab 64 IFL protocol 61 Folfox protocol 61 Trastuzumab 54 Panitumumab 47 durvalumab 46 Ramucirumab 43 Injections 43 Sunitinib 41 Drug Therapy 41 Carboplatin 40 trifluridine tipiracil drug combination 38 lenvatinib 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hepatectomy × Gastrointestinal × Clear all

NCT04597710 2026-05-29

Precision1

Perspectum

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡